Safety and Efficacy of Aliskiren/Amlodipine/Hydrochlorothiazide Triple Combination in Patients With Moderate to Severe Hypertension: A 54‐Week, Open‐Label Study

J Clin Hypertens (Greenwich). 2012; 14:821–827. ©2012 Wiley Periodicals, Inc. Combination antihypertensive therapies are recommended to attain blood pressure (BP) targets especially in high‐risk patients in whom rapid and pronounced BP control is essential. This 28‐ to 54‐week, open‐label, multicent...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Hypertens (Greenwich)
Autores principales: Murray, Alexander V., Koenig, Wolfgang, Garcia‐Puig, Juan, Patel, Samir, PhD, Alkaz Uddin, Zhang, Jack
Formato: Artigo
Lenguaje:Inglês
Publicado: Blackwell Publishing Ltd 2012
Materias:
Original Papers
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8108980/
https://ncbi.nlm.nih.gov/pubmed/23205748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1751-7176.2012.00706.x
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares